supergut glp 1 reviews before and after My first year off GLPs | Success Story GLP-1, GLP1/GIP, and Triple G:

Clinical trials have demonstrated varying degrees of weight loss depending on the specific agent and dosage: semaglutide 2.4mg (Wegovy) produces approximately 15% weight loss at 68 weeks, liraglutide 3mg (Saxenda) typically achieves 5-8% weight loss, while tirzepatide has shown up to 20% weight reduction in obesity trials

The Look AHEAD Research Group

It is about matching a medication to your health profile, your goals, and your ability to stay on it long-term

For brands, the smartest strategy is not reacting to the trend, it is building the research foundation to stay ahead of it

You dont have to go through it alone

Two large, randomized control trials investigating liraglutide and semaglutide have suggested worsening retinopathy as an adverse effect of GLP-1RA use